2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH SUSAN HALABI
Racial Disparities in Prostate Cancer Treatment and Outcomes

VIEW ALL ASCO GU 2019 VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH MICHAEL HOFMAN
Theranostic Approaches for Advanced Prostate Cancer

VIEW ALL ASCO GU 2019 VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH KARIM FIZAZI
ARAMIS - Efficacy and Safety of Darolutamide in nmCRPC

VIEW ALL ASCO GU 2019 VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH MATTHEW GALSKY
Combination Approaches with Immune-Checkpoint Blockade in Bladder Cancer

VIEW ALL ASCO GU 2019 VIDEOS

Featured Videos

24th Int'l Prostate Cancer Update: Poster - Hematologic Safety of radium-223 dichloride (radium-223) in castration-resistant prostate cancer patients with bone metastases from the phase 3 ALSYMPCA trial: Baseline prognostic factor subgroup analysis

VAIL, CO USA (UroToday.com) - Presented by Joe M. O’Sullivan, Dimitris Voliotis, Dag Clement Johannessen, Anders Widmark, Isabel Syndikus, Nicholas James, Marcos Dall’Oglio, Ingvild Haugen, Andrew Cross, Jose Garcia- Vargas, and Nicholas Vogelzang at the 24th International Prostate Cancer Update - February 19 - 22, 2014 - Cascade Conference Center - Vail, Colorado USA

IPCU 2014 OSullivan thumb

Centre for Cancer Research and Cell Biology, Queen’s University, Belfast, Northern Ireland;
Bayer HealthCare, Whippany, NJ, USA;
Ullevål University Hospital, Oslo, Norway;
Umeå University,Umeå, Sweden;
Clatterbridge Center for Oncology, Wirral, UK;
Cancer Research UK Clinical Trials Unit, School of Cancer Sciences, Birmingham, UK;
Hospital das Clínicas, Faculdade de Medicina da USP, Instituto do Câncer do Estado de São Paulo, Brazil;
Algeta ASA, Oslo, Norway;
Sheffield Hallam University, Sheffield, UK;
Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA
 

Click HERE to read the abstract from this session

 

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 3 Issue 4

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe